Cordis Announces Successful First-in-Human Use of the Radianz Radial Peripheral System™
Retrieved on:
Thursday, June 16, 2022
FACC, ACV, Heart, CLI, Osteopathic medicine in the United States, PAD, Artery, Amputation, Advanced cardiac life support, Patient satisfaction, S.M.A.R.T., Peripheral artery disease, MIAMI, Michigan State University College of Osteopathic Medicine, Systematic review, Quality of life, Extremities, History, Patient, Vascular disease, BRITE, University college, Medical device, Pharmaceutical industry, Cordis, Medicine, MD
MIAMI LAKES, Fla., June 16, 2022 /PRNewswire/ -- Cordis, a global leader in cardiovascular technologies, today announced the first-in-human use of the Radianz Radial Peripheral System™ by Jihad Mustapha, MD, FACC, FSCAI at Advanced Cardiac & Vascular Centers (ACV) in Grand Rapids, Michigan.
Key Points:
- The Radianz Radial Peripheral System solution includes BRITE TIP RADIANZGuiding Sheath used to optimize lower extremity lesion access, the SABERX RADIANZPTA Catheter to facilitate treatment, and the S.M.A.R.T.
- Radianz Radial Peripheral System is purposely engineered for radial access, which is proven to produce fewer vascular complications and higher patient satisfaction than femoral approaches.
- In addition to the well-documented clinical benefits ofthe Radianz Radial Peripheral System, radial access can reduce the total cost of care.
- The Radianz Radial Peripheral Systemportfolio is expected to launch later this year in the U.S. and in the near future in Japan.